Robert E. Gagnon
CIK 1504983 · Chief Financial Officer · last filed 2026-06-11
Robert E. Gagnon is a Chief Financial Officer who has filed 96 SEC Form 4 insider transactions across 6 companies since 2010. The most recent filing, for IRD, was dated Jul 23, 2026. Across all open-market trades the lifetime net is −$4.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.25M
6
96
-$4.11M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| HBIO | Chief Financial Officer | 27,556 | $5.92 | $163.1K | -$2.37M | 26 | 2026-06-11 |
| Opus Genetics, Inc. (OCUP) Delisted | Chief Financial Officer | 592,158 | $1.17 | $692.8K | -$40.7K | 3 | 2026-04-27 |
| VSTM | Director | 41,678 | $6.23 | $259.7K | -$338.4K | 33 | 2025-12-18 |
| BBLGW | Director | — | $10.00 | — | $0 | 3 | 2025-06-06 |
| CLEAN HARBORS INC (CLHB) Delisted | EVP CFO and Treasurer | 5,000 | — | — | $0 | 1 | 2012-09-13 |
| BIIB | Vice President, Finance | 3,999 | $205.61 | $822.2K | -$1.37M | 23 | 2012-03-01 |
Recent Filings
96 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-23 | IRD | Notice (144) | −7,783 | -$23.7K | EDGAR |
| 2026-07-23 | VSTM | Notice (144) | −31,924 | -$188.0K | EDGAR |
| 2026-06-25 | VSTM | Notice (144) | −21,492 | -$90.5K | EDGAR |
| 2026-06-11 | HBIO | Grant (A) | +16,556 | $0 | EDGAR |
| 2026-05-27 | VSTM | Notice (144) | −20,103 | -$87.6K | EDGAR |
| 2026-04-27 | Opus Genetics, Inc. (OCUP) Delisted | Sell (S) | −7,842 | -$40.7K | EDGAR |
| 2026-04-23 | IRD | Notice (144) | −7,842 | -$40.7K | EDGAR |
| 2026-01-26 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +400,000 | $0 | EDGAR |
| 2025-12-18 | VSTM | Sell (S) | −283 | -$2.6K | EDGAR |
| 2025-09-18 | VSTM | Sell (S) | −281 | -$2.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.